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INTRODUCTION 
The establishment and spread of highly 
pathogenic avian influenza (HPAI) viruses of the 
H5N1 subtype in birds and coincident infections in 
humans since 2003 have raised concerns that we 
may be facing an influenza pandemic caused by an 
H5N1 influenza virus [4]. Globally, from January 
2003 to 2 March 2017, there were 860 cases of 
human infection with avian influenza A(H5N1) 
virus reported from 16 countries worldwide. Of 
these 860 cases, 454 were fatal (CFR of 53%). The 
last case was reported from Indonesia on 26 
September 2017 [7]. Although the human cases of 
H5N1 in Indonesia has decreased significantly 
since 2010, according to WHO until 2017 there 
have been reported 200 cases H5N1 in  human with 
168 cases of deaths. The last case was reported 
from Indonesia on 26 September 2017. This is 
indicate Indonesia as the highest fatal case of H5N1 
globally. With continued incidence of avian 
influenza due to existing AI H5N1 viruses in 
poultry, the avian influenza H5N1 has been 
believed remain to threaten Indonesia [6].  
Passive immunization using specific 
antibody against AI H5N1 from bovine colostrum is 
one of an alternative to control H5N1 virus 
infection due to lack of H5N1 vaccine production 
for human. Bovine colostrums consider an ideal 
alternative antibody source, as the antibody in the 
bovine’s blood is transported to mammary gland 
easily and accumulates in the colostrum in large 
quantities. As a “biological factory”  and the source 
of natural antibody, bovine colostrum could be 
designed to produce the specific antibody against 
certain disease for animal and human by 
immunizing the dry cow (with the antigen of 
interest).  
Vaccine is an antigenic material used to 
produce active immunity against diseases. 
Vaccination is the administration of vaccine to the 
individual to generate immunity against a disease 
[2]. According to [1], the exposure of a dry cow 
against antigen (vaccine) will produce specific 
antibody in their blood circulation. Therefore, 
evaluation on the status of antibody against AI 
H5N1 following the vaccination of dry Holstein 
cows with killed AI H5N1 vaccine is needed.   
 
MATERIALS AND METHODS 
Dry Holstein cows, on 2nd-3th lactation, 
clinically healthy, were divided into 2 groups, 
control (n=3) and treatment (n=7). The treatment 
group were injected by commercial killed avian 
influenza (AI) H5N1 vaccine subcutaneously, 
double doses/head, three times every two weeks. 
Blood samples were collected from coccygeal vein, 
starting before the 1st vaccination (0 week), 
repeated every two weeks until calving for serum 
antibody against AI H5N1 analysis. Serum antibody 
against AI H5N1 were detected using 
haemagglutination inhibition test [8]. 
  
RESULT AND DISCUSSION 
Results of this study showed that the 
administration of avian influenza H5N1 killed 
vaccine double doses per head, three times every 
two weeks may induce the formation of antibody 
against AI H5N1 in their blood. However, the ability 
of antibody induction are various among individual 
cows.  Out of seven cows vaccinated, one cow did 
not show antibody against H5N1 AI in her blood. 
The remaining six cows expressed enough titer 
(detectable and protective amounts) of antibody 
(Table 1). 
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Table 1 Titer of serum antibody of Holstein cows vaccinated  by Killed AI H5N1 Vaccine  
Cow  
Code 
Titer  of Antibody Against AI H5N1 (log 2) 
 
Before Vaccination 
 
Two Weeks After 1st 
Vaccination  
 
Two Weeks After 2nd 
Vaccination 
 
Two weeks After 
3rd Vaccination 
 
Control     
118 0 0 0 0 
1719 0 0 0 0 
1767 0 0 0 0 
Vaccinate
d     
888 0 0 0 5 
1862 0 0 0 0 
1587 0 0 0 3 
30 0 3 3 5 
220 0 2 3 4 
713 0 4 4 5 
776 0 3 4 5 
Although the majority (85%) of vaccinated 
cows have shown the ability to produce antibodies, 
the variation among individuals were observed on 
the onset of antibody detected. Four out of seven 
vaccinated cows responded very well, showing 
high antibody titer (cows code 30, 220, 713, 776). 
Specific antibody against H5N1 were detected in 
their blood serum using HI test two weeks 
following the 1st vaccination, with the titer as high 
as 22-24. After the second administration of vaccine 
(booster) the titer of antibody continued to 
increase until two weeks after the 3rd vaccination, 
with the titer of antibody between 24-25. The serum 
antibody anti H5N1 AI was detected later (two 
weeks after the 3rd vaccination) with the titer 
between 23-25 in two remaining cows.  One more 
cow (cow code 1862) was failed to show the 
antibody titer in her perifer blood (titer 20) even 
after 2 weeks following the 3rd vaccination.  
A various factors involve on the formation 
of antibody such as age, molecule size of antigen, 
the complexity of chemical structure of antigen, 
genetic, route of immunization, antigen dose and, 
the timing and frequency of immunization [3]. It 
has been reported that the body condition of the 
animal play an important role on the antibody 
formation. The body condition interfered by the 
feed, qualitatively and quantitatively. This has 
involve at the physiological condition and the 
immune response. On the other hand, stress, barn 
condition and the time of sampling may affect 
antibody concentration [5]. 
Vaccination is the administration of 
antigen collected from contageous agent. When 
exposed to other protein, the body will respond to 
the cellular and humoral immunity. In the immune 
system, the immunity mediated by cells (T-
lymphocytes), and provide cellular immunity by 
activating T-lymphocytes and lymphokines. On the 
other side, cells generated from humoral system 
(B-lymphocytes) provides a response on the 
antigenic challenge by providing the specific 
antibody. The antibody will be released in the 
blood and other body fluid [5]. 
 
CONCLUSION 
Dry Holstein cows vaccinated by 
commercial killed Avian Influenza H5N1 vaccine 
subcutaneously, double doses, three times every 
two weeks were able to produce specific antibody 
against antigen virus AI H5N1 in their blood. Dry 
Holstein cows were very responsive to AI H5N1 
antigen injected. Dry cows could be immunized by 
commercial killed AI H5N1 vaccine and produce 
the antibody against AI H5N1 in their blood in 
detectable and protective amounts. 
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